Cartesian Therapeutics Ownership | Who Owns Cartesian Therapeutics?

Overview Forecast RevenueFinancials Chart

Cartesian Therapeutics Ownership Summary

Cartesian Therapeutics is owned by 24.62% institutional investors, 59.85% insiders, and 15.53% retail investors. Bioimpact capital is the largest institutional shareholder, holding 2.64% of RNAC shares. Fidelity Select Biotechnology is the top mutual fund, with 2.60% of its assets in Cartesian Therapeutics shares.

RNAC Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	Cartesian Therapeutics	24.62%	59.85%	15.53%
Sector	Healthcare Stocks	486.50%	11.08%	-397.59%
Industry	Biotech Stocks	304.14%	11.08%	-215.23%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Bioimpact capital	686.01K	2.64%	$7.13M
Blackrock funding, inc. /de	653.84K	2.52%	$6.79M
Siren	563.27K	2.17%	$5.85M
683 capital management	219.00K	0.84%	$2.28M
Marshall wace, llp	82.63K	0.32%	$858.53K
Freestone capital	25.92K	0.10%	$269.32K
Ikarian capital	22.17K	0.09%	$230.30K
Delphi financial group	22.03K	0.08%	$228.87K
Virtus investment advisers	9.18K	0.04%	$95.41K
Mirae asset global investments	4.72K	0.02%	$11.09K

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Bioimpact capital	686.01K	1.24%	$7.13M
Siren	563.27K	0.30%	$5.85M
Delphi financial group	22.03K	0.16%	$228.87K
683 capital management	219.00K	0.15%	$2.28M
Ikarian capital	22.17K	0.04%	$230.30K
Virtus investment advisers	9.18K	0.03%	$95.41K
Freestone capital	25.92K	0.01%	$269.32K
Marshall wace, llp	82.63K	0.00%	$858.53K
Alerus financial na	1.00K	0.00%	$10.39K
Activest wealth management	66.00	0.00%	$686.00

Top Buyers

Holder	Shares	% Assets	Change
683 capital management	219.00K	0.15%	69.00K
Marshall wace, llp	82.63K	0.00%	44.02K
Virtus investment advisers	9.18K	0.03%	1.02K
Alerus financial na	1.00K	0.00%	1.00K
Sterling capital management	223.00	-	209.00

Top Sellers

Holder	Shares	% Assets	Change
Bioimpact capital	686.01K	1.24%	-104.77K
Alps advisors	-	-	-19.39K
Blackrock funding, inc. /de	653.84K	0.00%	-19.21K
Boothbay fund management	-	-	-14.49K
Two sigma investments, lp	-	-	-11.02K

New Positions

Holder	Shares	% Assets	Change	Value
Alerus financial na	1.00K	0.00%	1.00K	$10.39K
Allworth financial lp	15.00	-	15.00	$156.00

Sold Out

Holder	Change
Ifp advisors	-1.00
True wealth design	-2.00
Truvestments capital	-10.00
Farther finance advisors	-18.00
Coldstream capital management	-29.00

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Jun 30, 2025	66	-2.94%	6,395,690	-2.83%	24	3.81%	29	-12.12%	18	-
Mar 31, 2025	68	4.62%	6,582,091	1.37%	25	145.00%	33	-25.00%	18	125.00%
Dec 31, 2024	66	6.45%	6,666,026	-2.94%	4	21.92%	45	28.57%	8	-11.11%
Sep 30, 2024	62	5.08%	6,868,068	109.92%	4	99.52%	35	-37.50%	9	200.00%
Jun 30, 2024	59	1375.00%	3,271,748	176274.56%	2	-	56	1300.00%	3	-

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
Fidelity Select Biotechnology	675.95K	2.60%	-
Fidelity Growth Compy Commingled Pl S	462.41K	1.78%	-
HBM Healthcare Investments AG Ord	415.23K	1.60%	-
Fidelity Select Health Care	368.99K	1.42%	-
Fidelity Growth Company Fund	341.04K	1.31%	-
Vanguard Total Stock Mkt Idx Inv	281.78K	1.08%	-6.21K
iShares Russell 2000 ETF	234.65K	0.90%	-4.41K
Fidelity Advisor Health Care I	230.25K	0.89%	-
Fidelity Advisor Biotechnology I	167.95K	0.66%	167.95K
Vanguard US Total Market Shares ETF	126.63K	0.49%	-

Recent Insider Transactions

Date	Name	Activity	Value
Apr 09, 2025	SPRINGER TIMOTHY A	Buy	$308.48
Apr 11, 2025	SPRINGER TIMOTHY A	Buy	$69.07K
Apr 10, 2025	SPRINGER TIMOTHY A	Buy	$6.65K
Apr 10, 2025	SPRINGER TIMOTHY A	Buy	$83.12K
Apr 09, 2025	SPRINGER TIMOTHY A	Buy	$69.21K

Insider Transactions Trends

Date	Buy	Sell
2025 Q2	10	-
2025 Q1	6	12
2024 Q4	20	17
2024 Q3	2	-
2024 Q2	-	-

RNAC Ownership FAQ

Who Owns Cartesian Therapeutics?

Cartesian Therapeutics shareholders are primarily institutional investors at 24.62%, followed by 59.85% insiders and 15.53% retail investors. The average institutional ownership in Cartesian Therapeutics's industry, Biotech Stocks , is 304.14%, which Cartesian Therapeutics falls below.

Who owns the most shares of Cartesian Therapeutics?

Cartesian Therapeutics’s largest shareholders are Bioimpact capital (686.01K shares, 2.64%), Blackrock funding, inc. /de (653.84K shares, 2.52%), and Siren (563.27K shares, 2.17%). Together, they hold 7.33% of Cartesian Therapeutics’s total shares outstanding.

Does Blackrock own Cartesian Therapeutics?

BlackRock is not among the top 10 institutional shareholders of Cartesian Therapeutics.

Who is Cartesian Therapeutics’s biggest shareholder by percentage of total assets invested?

Bioimpact capital is Cartesian Therapeutics’s biggest shareholder by percentage of total assets invested, with 1.24% of its assets in 686.01K Cartesian Therapeutics shares, valued at 7.13M$.

Who is the top mutual fund holder of Cartesian Therapeutics shares?

Fidelity Select Biotechnology is the top mutual fund holder of Cartesian Therapeutics shares, with 2.60% of its total shares outstanding invested in 675.95K Cartesian Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools